Gabriel Joseph

Gabriel Joseph, M.S., is a highly experienced professional in the field of Quality Control (QC) and analytics, currently serving as a Senior QC Analyst at Iovance Biotherapeutics, Inc. Since May 2023, Gabriel has focused on QC analytics for TIL-Cell therapy targeted at cancer treatments. Previously, Gabriel held the position of Senior Scientist at Bristol Myers Squibb from April 2022 to May 2023, where responsibilities included training QC Analytical associates and establishing a learning culture within the organization. Prior roles include work as a Scientist in QC analytics at Novartis, specializing in cell and gene therapies, and as a Biologic Clinical Development Scientist at Janssen BioPharmaceuticals. Gabriel possesses a Master’s degree in Microbiology from Jefferson Health and a Bachelor's degree in Microbiology from West Chester University of Pennsylvania.